Skip to page content |

Tiscali Quicklinks. Please visit our Accessibility Page for a list of the Access Keys you can use to find your way around the site, skip directly to the main navigation, to the page content, or to more links within lifestyle.

Note: You are reading this message because you might not be able to see our stylesheets, or because you might not have a standards-compliant browser.

Although the content of this site will be accessible in any browser, please consider upgrading to a web standards-compliant browser such as Firefox, Netscape, Opera, or Internet Explorer to better enjoy the new design and functionality of our site (all links open in a new window).


From: www.tiscali.co.uk/lifestyle/
tiscali


Health and Nutrition > Medicines > D

Dihydroergotamine (discontinued in the UK - March 2001) (Contd)




Side effects

Medicines and their possible side effects can affect individual people in different ways. The following are some of the side effects that are known to be associated with this medicine. Because a side effect is stated here, it does not mean that all people using this medicine will experience that or any side effect.

  • Diarrhoea
  • Pins and needles (paraesthesia)
  • Nausea and vomiting
  • Inflammation of the throat (pharyngitis)
  • Flushing
  • Alteration in taste
  • Narrowing of the blood vessels in the extremities of the body (peripheral vasoconstriction)
  • Inflammation of the lining of the nose (rhinitis) causing a blocked or runny nose
  • Chest pain
  • Runny and stuffy nose
  • The side effects listed above may not include all of the side effects reported by the drug's manufacturer. For more information about any other possible risks associated with this medicine, please read the information provided with the medicine or consult your doctor or pharmacist.

    How can this medicine affect other medicines?

    The use of dihydroergotamine with the macrolide antibiotics (erythromycin, troleandomycin, josamycin or midecamycin) is contraindicated. The combination can cause an increase in the levels of dihydroergotamine which may lead to serious adverse effects. The use of ritonavir with dihydroergotamine is contraindicated as the combination may potentially lead to serious adverse effects. The use of other ergot alkaloids, sumatriptan, nicotine (eg. heavy smoking), and other medicines which bind to serotoinin receptors should be avoided when taking dihydroergotamine. These combinations may enhance the narrowing of blood vessels which may lead to adverse effects. If these medicines are to be used, they should be taken at least 24 hours after the dose of dihydroergotamine.

    Other medicines containing the same active ingredients

    Migranal


    <<Go To Page 1

    The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care or attention by a qualified practitioner. The materials in this web site cannot and should not be used as a basis for diagnosis or choice of treatment. Conditions for use

    Powered by netdoctor

    © Copyright 1998 - 2004 NetDoctor.co.uk - All rights reserved

    Related Links

    health search
    Search all
    Diseases
    Medicines
    medicines by alphabet
    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    health search
    Search all
    Diseases
    Medicines